Nephrology Grand Rounds: SGLT2 Inhibitors
medcases00
Published on Aug 22, 2021
Prof Heerspink from UMC Groningen presented at Nephrology Grand Rounds on December 17th 2020
The topic was Flozination, ie the use of SGLT2 inhibitors, in not just type 2 diabetes, but in non-diabetic CKD
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
53:09SGLT2 Inhibitors in Type 2 DM: A Cardiorenal "Game-Changer"
20 views 1265 days ago -
Watch Later
55:16 -
Watch Later
34:00Iris De Castro, MD - SGLT2 inhibitor in Kidney Transplantation: Is it ready for prime time?
17 views 1088 days ago -
Watch Later
![Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury]()
45:18Onconephrology Updates: Immune Checkpoint Inhibitors and Kidney Injury
16 views 834 days ago -
Watch Later
![CommonSpirit Health Grand Rounds/Clinical Update: Evidence-Based Approach to Renal Function Estimate]()
54:31
